West Pharmaceutical Raises 2026 Outlook as Sales Accelerate
EXTON, PA — West Pharmaceutical Services Inc. (NYSE: WST) raised its full-year sales and earnings guidance after second-quarter revenue increased 13.8%, driven by demand for high-value components used in biologics, …
West Pharmaceutical Raises 2026 Outlook as Sales Accelerate Read More